Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence
dc.contributor.author | Higgs, Peter | |
dc.contributor.author | Sacks-Davis, R. | |
dc.contributor.author | Gold, J. | |
dc.contributor.author | Hellard, M. | |
dc.date.accessioned | 2017-07-27T05:20:56Z | |
dc.date.available | 2017-07-27T05:20:56Z | |
dc.date.created | 2017-07-26T11:11:11Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Higgs, P. and Sacks-Davis, R. and Gold, J. and Hellard, M. 2011. Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence. Hepatitis Monthly. 11 (7): pp. 513-518. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/54407 | |
dc.description.abstract |
Background: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. Objectives: We reviewed the literature to obtain an evidence base for these common exclusion criteria. Materials and Methods: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. Results: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. Conclusions: Currently, there is a lack of evidence for many of the barriers faced by patients in availing treatment for hepatitis C. Adherence to treatment routine was found to be a better predictor of sustained virological response than injecting drug or alcohol consumption during treatment period or the presence of a pre-existing mental disorder. Although several challenges remain, we need to ensure that treatment decisions are based on the best available evidence and the treatment is performed appropriately on a case-by-case basis. © 2011 Kowsar M.P.Co. All rights reserved. | |
dc.publisher | Tehran Hepatitis Center | |
dc.title | Barriers to receiving hepatitis c treatment for people who inject drugs myths and evidence | |
dc.type | Journal Article | |
dcterms.source.volume | 11 | |
dcterms.source.number | 7 | |
dcterms.source.startPage | 513 | |
dcterms.source.endPage | 518 | |
dcterms.source.issn | 1735-143X | |
dcterms.source.title | Hepatitis Monthly | |
curtin.department | National Drug Research Institute (NDRI) | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |